Attanasi Michael L, Gregoski Mathew J, Rockey Don C
Department of Internal Medicine, North Shore University Hospital, Manhasset, NY, USA.
Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Dig Dis Sci. 2025 Mar 18. doi: 10.1007/s10620-025-08936-w.
BACKGROUND & AIMS: Liver histology is the classic method for staging the severity of liver fibrosis, which in turn is an important predictor of clinical outcome. Here, we have hypothesized that the susceptibility to develop fibrosis varies among racial groups.
We examined the histology of all patients over 18 years of age who underwent liver biopsy at the Medical University of South Carolina from 1/1/2013 to 7/1/2021. Patients with malignancy, liver metastases, or missing data were excluded. Fibrosis was quantified using the Batts-Ludwig system (F0 = no fibrosis to F4 = histological cirrhosis). Racial groups were propensity matched based on age, gender, diabetes, alcohol consumption, and CDC/ATSDR Social Vulnerability Index Themes to mitigate the risk of selection bias.
We identified 1101 patients with liver biopsy histological fibrosis scores. The cohort included 23% Black patients. After propensity matching, Black patients were significantly more likely to have Hepatitis C (73/228 (32%) vs 45/228 (20%), p < 0.001) and autoimmune hepatitis (34/228 (15%) vs 6/228 (3%), p < 0.001) than White patients, while White patients were significantly more likely to have metabolic dysfunction associated steatotic liver disease (71/228 (31%) vs 18/228 (8%), p < 0.001). White patients were significantly more likely to have cirrhosis than Black patients (White - 89/228 (39%) vs Black - 68/228 (30%), p < 0.05).
White patients had a greater overall burden of advanced fibrosis (F4/cirrhosis) than Black patients, independent of etiology. The data suggest that fibrosis risk and/or progression may be worse in White than Black patients.
肝脏组织学是对肝纤维化严重程度进行分期的经典方法,而肝纤维化又是临床结局的重要预测指标。在此,我们假设不同种族群体发生纤维化的易感性存在差异。
我们对2013年1月1日至2021年7月1日在南卡罗来纳医科大学接受肝活检的所有18岁以上患者的组织学情况进行了检查。排除患有恶性肿瘤、肝转移或数据缺失的患者。使用巴茨-路德维希系统对纤维化进行量化(F0 = 无纤维化至F4 = 组织学肝硬化)。根据年龄、性别、糖尿病、饮酒情况以及疾病控制与预防中心/美国毒物与疾病登记署社会脆弱性指数主题对种族群体进行倾向匹配,以降低选择偏倚风险。
我们确定了1101例有肝活检组织学纤维化评分的患者。该队列包括23%的黑人患者。倾向匹配后,黑人患者患丙型肝炎(73/228(32%)对45/228(20%),p < 0.001)和自身免疫性肝炎(34/228(15%)对6/228(3%),p < 0.001)的可能性显著高于白人患者,而白人患者患代谢功能障碍相关脂肪性肝病的可能性显著高于黑人患者(71/228(31%)对18/228(8%),p < 0.0